With the name of the firm - AMES - an acronym for Assisted Movement with Enhanced Sensation, AMES Technology Inc âs initial product line of medical devices is based on AMES technology, Spun out of Oregon Health & Science University AMES Technology, Inc. is focused on developing innovative medical devices in the field of neurorehabilitation. AMES utilizes patented therapeutic technology, which specifically enhances and repairs sensory input and motor output connections in the brain for individuals recovering from stroke and other neurological impairments. AMES exploits the ability of the adult brain to reorganize itself in response to changes in sensory input or to changes in motor output. The AMES technology, which is founded on the hypothesis that assisted movement and enhanced sensation, used together, promotes the functional reorganization (plasticity) of sensorimotor pathways in the brain, is based on a decade of research conducted by founder Dr. Paul Cordo, senior researcher and former Director of the Neurological Sciences Institute at The company is headquartered in Portland, Oregon. To date, the company has raised over $5 million to fund the development of a rehabilitation medical device and to fund a number of clinical studies on participants with stroke and incomplete spinal cord injury. AMES is now poised to commercialize the first of its products - the AMES Rehabilitation Therapy Medical Device. AMES Technology, Inc. is a spin-off company from Oregon Health & Science University focused on developing innovative medical devices in the field of neurorehabilitation. The company is headquartered in Portland, Oregon. To date, the company has raised over $5 million to fund the development of a rehabilitation medical device and to fund a number of clinical studies on participants with stroke and incomplete spinal cord injury. AMES is now poised to commercialize the first of its products - the AMES Rehabilitation Therapy Medical Device
